W. R. Berkley Corporation · WRB · FY2026 Q3 · Calendar Q4 2026
W.R. Berkley pairs record underwriting profit with selective growth
W.R. Berkley's earnings profile remains supported by disciplined underwriting, investment income, and technology-enabled efficiency. The thesis is constructive but conditional: commercial property pressure, lower reinsurance volume, and emerging liability risks could limit the durability of current underwriting gains.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about WRB FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior quarter, the analysis points to a stronger Q3 underwriting result and a more explicit near-term split between attractive liability and private-client opportunities and tougher commercial-property conditions. Management also highlighted emerging AI, robotics, and autonomous-vehicle risks, while maintaining its growth outlook and planned technology, capital, and portfolio-duration initiatives.
Guidance delta
Management maintained its outlook: insurance premium growth is expected to remain mid-single-digit, while reinsurance volume is expected to contract 10–20% annually.
Key takeaways
- The company reported record Q3 underwriting profit and an 88.1% operating combined ratio excluding catastrophes.
- Management said technology and data analytics are improving underwriting intake and claims efficiency by more than 20%.
- Insurance growth remains focused on smaller commercial accounts, private client business, and selected liability and professional lines.
- Commercial property is more challenging, while management expects reinsurance volume to decline 10–20% annually.
- The fixed-income portfolio supports earnings, but unrealized losses increased as interest rates affected bond values.
Management priorities
- Use data and AI to improve underwriting and claims efficiency.
- Maintain pricing discipline while pursuing small-account growth and attractive liability and professional lines.
- Gradually extend portfolio duration to capture higher yields.
- Preserve excess capital while continuing shareholder returns.
- Monitor emerging risks tied to autonomous vehicles, robotics, and AI-related liability.
Follow WRB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 20, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Underweight | Underweight | Maintain | Oct 12, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Oct 7, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Oct 7, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 6, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 27, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 21, 2026 |
| B of A Securities | Underperform | Neutral | Downgrade | Jul 16, 2026 |
| Evercore ISI Group | Underperform | Underperform | Maintain | Jul 10, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 8, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jun 12, 2026 |
| Goldman Sachs | Buy | Neutral | Upgrade | Jun 8, 2026 |
| Argus Research | Hold | Buy | Downgrade | Apr 27, 2026 |
| BMO Capital | Market Perform | Underperform | Upgrade | Apr 23, 2026 |
| Jefferies | Hold | Hold | Maintain | Jan 27, 2026 |
| TD Cowen | Sell | Hold | Downgrade | Jan 20, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jan 28, 2025 |
| Janney Montgomery Scott | Buy | Buy | Maintain | Nov 11, 2022 |
| Boenning & Scattergood | Outperform | Neutral | Upgrade | Sep 20, 2021 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 21, 2021 |
| Credit Suisse | Outperform | Outperform | Maintain | Jan 11, 2021 |
| CFRA | Hold | Hold | Maintain | Apr 24, 2020 |
| Buckingham Research | Buy | Neutral | Upgrade | Jan 22, 2020 |
| Buckingham | Buy | Neutral | Upgrade | Jan 22, 2020 |
| Bank of America | Underperform | Neutral | Downgrade | Jun 14, 2018 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Sep 21, 2015 |
| Keefe Bruyette & Woods | Market Perform | Market Perform | Maintain | Oct 27, 2014 |
| Compass Point | Neutral | Neutral | Maintain | Oct 27, 2014 |
| Macquarie | Neutral | Neutral | Maintain | Oct 16, 2013 |
| Citigroup | Neutral | Neutral | Maintain | Oct 12, 2012 |
| BGB Securities | Hold | Buy | Downgrade | Apr 25, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $73.82. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $65 | $71.91 | -11.9% | Oct 12, 2026 |
| Mizuho Securities | Analyst unavailable | $70 | $69.65 | -5.2% | Oct 7, 2026 |
| Morgan Stanley | Bob Huang | $70 | $70.14 | -5.2% | Oct 6, 2026 |
| UBS | Analyst unavailable | $77 | $75.61 | +4.3% | Jul 27, 2026 |
| Mizuho Securities | Analyst unavailable | $74 | $72.71 | +0.3% | Jul 21, 2026 |
| Oppenheimer | Analyst unavailable | $70 | $72.71 | -5.2% | Jul 21, 2026 |
| Atlantic Equities | Analyst unavailable | $74 | $70.68 | +0.3% | Jul 15, 2026 |
| Evercore ISI | Analyst unavailable | $68 | $72.02 | -7.9% | Jul 10, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $74 | $71.28 | +0.3% | Jul 9, 2026 |
| Mizuho Securities | Yaron Kinar | $72 | $71.28 | -2.5% | Jul 9, 2026 |
| Barclays | Alex Scott | $62 | $67.54 | -16.0% | Jun 12, 2026 |
| Wells Fargo | Analyst unavailable | $58 | $68.57 | -21.4% | Jun 8, 2026 |
| UBS | Analyst unavailable | $68 | $66.64 | -7.9% | Apr 27, 2026 |
| BMO Capital | Analyst unavailable | $68 | $67.5 | -7.9% | Apr 23, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $71 | $67.21 | -3.8% | Apr 9, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $75 | $67.87 | +1.6% | Feb 2, 2026 |
| UBS | Analyst unavailable | $71 | $68.58 | -3.8% | Feb 2, 2026 |
| Morgan Stanley | Analyst unavailable | $73 | $67.5 | -1.1% | Jan 28, 2026 |
| Truist Financial | Analyst unavailable | $80 | $67.09 | +8.4% | Jan 27, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $76 | $69.6 | +3.0% | Jan 14, 2026 |
| Mizuho Securities | Yaron Kinar | $69 | $68 | -6.5% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $68 | $68.71 | -7.9% | Jan 13, 2026 |
| Barclays | Alex Scott | $64 | $69.29 | -13.3% | Jan 8, 2026 |
| Goldman Sachs | Analyst unavailable | $73 | $68.49 | -1.1% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $69 | $69.99 | -6.5% | Jan 7, 2026 |
| Morgan Stanley | Analyst unavailable | $75 | $69.1 | +1.6% | Dec 16, 2025 |
| Mizuho Securities | Analyst unavailable | $67 | $69.1 | -9.2% | Dec 15, 2025 |
| Morgan Stanley | Analyst unavailable | $80 | $77.51 | +8.4% | Nov 17, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $78 | $75.1 | +5.7% | Oct 27, 2025 |
| BMO Capital | Analyst unavailable | $64 | $75 | -13.3% | Oct 22, 2025 |
| Truist Financial | Analyst unavailable | $84 | $73.48 | +13.8% | Oct 21, 2025 |
| Wells Fargo | Elyse Greenspan | $66 | $73.48 | -10.6% | Oct 21, 2025 |
| Jefferies | Andrew Andersen | $75 | $73.48 | +1.6% | Oct 21, 2025 |
| UBS | Analyst unavailable | $87 | $77.77 | +17.9% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $73 | $77.77 | -1.1% | Oct 8, 2025 |
| Cantor Fitzgerald | Ryan Tunis | $82 | $70.01 | +11.1% | Aug 12, 2025 |
| Wells Fargo | Elyse Greenspan | $70 | $70.85 | -5.2% | Apr 22, 2025 |
| Goldman Sachs | Robert Cox | $69 | $62.27 | -6.5% | Nov 25, 2024 |
| CFRA | Catherine Seifert | $67 | $59.13 | -9.2% | Oct 23, 2024 |
| UBS | Brian Meredith | $69 | $58.53 | -6.5% | Oct 22, 2024 |
| Bank of America Securities | Joshua Shanker | $76 | $61.03 | +3.0% | Oct 22, 2024 |
| RBC Capital | Scott Heleniak | $63 | $61.03 | -14.7% | Oct 22, 2024 |
| Goldman Sachs | Alex Scott | $61 | $61.03 | -17.4% | Oct 22, 2024 |
| Evercore ISI | David Motemaden | $60 | $61.03 | -18.7% | Oct 22, 2024 |
| Truist Financial | Mark Hughes | $68 | $59.28 | -7.9% | Oct 17, 2024 |
| Jefferies | Yaron Kinar | $57 | $57.47 | -22.8% | Oct 9, 2024 |
| Barclays | Alex Scott | $56 | $60.58 | -24.1% | Sep 4, 2024 |
| Wells Fargo | Elyse Greenspan | $59 | $51.82 | -20.1% | Jul 23, 2024 |
| Goldman Sachs | Alex Scott | $83 | $78.17 | +12.4% | Jun 13, 2024 |
| BMO Capital | Michael Zaremski | $89 | $78.04 | +20.6% | Apr 25, 2024 |
| RBC Capital | Scott Heleniak | $88 | $86.61 | +19.2% | Apr 5, 2024 |
| Morgan Stanley | Analyst unavailable | $68 | $67.7 | -7.9% | Apr 27, 2022 |
| Morgan Stanley | Analyst unavailable | $67 | $66.69 | -9.2% | Apr 25, 2022 |
| Morgan Stanley | Analyst unavailable | $44.67 | $71.05 | -39.5% | Apr 21, 2022 |
| UBS | Brian Meredith | $40.93 | $21.72 | -44.6% | Jul 26, 2021 |
| Deutsche Bank | Phil Stefano | $53.36 | $34.88 | -27.7% | Apr 21, 2021 |
Track every rating change on WRB the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationW. R. Berkley Corporation functions as an insurance holding company, primarily underwriting commercial policies across the United States and globally. Its extensive operations are divided into two principal divisions: Insurance, and Reinsurance & Monoline Excess. The Insurance segment delivers a wide spectrum of commercial insurance solutions. This includes foundational coverages such as general liability, property, commercial auto, and professional liability, alongside specialized offerings like workers' compensation, environmental policies for diverse businesses, directors and officers (D&O) liability, cyber risk protection, and niche policies for fine arts and jewelry.…
Historical context
All WRB earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SYF-PB Synchrony Financial | FY2026 Q3 · Calendar Q4 2026 | — | — | Synchrony holds top-end EPS guidance as digital initiatives expand |
| WRB-PG W.R. Berkley Corporation 4.25% | FY2026 Q3 · Calendar Q4 2026 | +1.7% | — | W.R. Berkley: Strong underwriting offsets reinsurance pressure |
| WRB-PH W.R. Berkley Corporation 4.125% | FY2026 Q3 · Calendar Q4 2026 | +1.7% | — | W.R. Berkley: Strong underwriting, deliberate reinsurance pullback |
| WRB-PE W. R. Berkley Corporation 5.70% SB DB 2058 | FY2026 Q3 · Calendar Q4 2026 | +1.7% | — | W.R. Berkley: Strong underwriting, disciplined growth and new AI risks |
| FITB Fifth Third Bancorp | FY2026 Q3 · Calendar Q4 2026 | +36.0% | +0.3% | Fifth Third completes Comerica integration as deposits and efficiency improve |
| IBN ICICI Bank Limited | FY2027 Q2 · Calendar Q4 2026 | +1.0% | — | ICICI Bank sustains strong growth, but funding weighs on margins |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the WRB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-20T14:02:50.754236+00:00
- FN2 earnings calendar · 2026-10-20T01:23:14.154112+00:00
- Polygon adjusted daily market bars · 2026-10-20T14:50:44.669517+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-20T14:50:44.666552+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-20. For educational purposes only; not investment advice.